sorafenib has been researched along with Connective Tissue Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Le Deley, MC; Penel, N; Ryckewaert, T | 1 |
1 review(s) available for sorafenib and Connective Tissue Neoplasms
| Article | Year |
|---|---|
Emerging Role of Multikinase Inhibitors in Desmoid Tumor Management.
Topics: Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Fibromatosis, Aggressive; France; Humans; Neoplasms, Connective Tissue; Protein Kinase Inhibitors; Randomized Controlled Trials as Topic; Sorafenib; Treatment Outcome | 2019 |